Charles River Laboratories (CRL)
Current ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 1,403,070 | 1,494,720 | 1,499,270 | 1,668,190 | 1,608,660 | 1,444,320 | 1,504,780 | 1,448,360 | 1,439,030 | 1,415,350 | 1,393,090 | 1,333,090 | 1,274,100 | 1,379,040 | 1,267,910 | 1,423,210 | 1,201,130 | 1,140,270 | 1,234,720 | 1,208,280 |
Total current liabilities | US$ in thousands | 994,101 | 1,012,220 | 947,519 | 954,810 | 1,055,080 | 993,816 | 1,007,620 | 981,392 | 1,091,580 | 1,014,190 | 1,048,140 | 993,839 | 1,033,180 | 983,751 | 929,610 | 803,376 | 839,751 | 787,014 | 727,936 | 690,896 |
Current ratio | 1.41 | 1.48 | 1.58 | 1.75 | 1.52 | 1.45 | 1.49 | 1.48 | 1.32 | 1.40 | 1.33 | 1.34 | 1.23 | 1.40 | 1.36 | 1.77 | 1.43 | 1.45 | 1.70 | 1.75 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $1,403,070K ÷ $994,101K
= 1.41
The current ratio of Charles River Laboratories has shown fluctuations over the years, ranging from a low of 1.23 on December 31, 2021, to a high of 1.77 on March 31, 2021. The current ratio measures the company's ability to meet its short-term obligations with its current assets. A ratio above 1 indicates that the company has more current assets than current liabilities, which is generally considered favorable.
On analyzing the trend, we observe that the current ratio has been relatively stable around the range of 1.30 to 1.50 in recent quarters, indicating that the company has a reasonable level of current assets to cover its short-term liabilities. However, it is essential to note the decrease from 1.58 on June 30, 2024, to 1.41 on December 31, 2024, which could merit further investigation to understand the underlying reasons for this decline.
Overall, the current ratio of Charles River Laboratories suggests that the company has maintained a healthy liquidity position over the periods analyzed, although management should continue to monitor and manage its current assets and liabilities effectively to ensure ongoing financial stability.
Peer comparison
Dec 31, 2024